The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Innovative Cellular Therapeutics Co (Inst)
Efficacy of anti-CD19 chimeric antigen receptor modified T(CAR-T) cell therapy in Chinese patients with relapsed/refractory acute lymphocytic leukemia in a multicenter trial.
 
Lei Xiao
Employment - Innovative Cellular Therapeutics Co
Leadership - Innovative Cellular Therapeutics Co
Stock and Other Ownership Interests - Innovative Cellular Therapeutics Co
Honoraria - Innovative Cellular Therapeutics Co
Patents, Royalties, Other Intellectual Property - Innovative Cellular Therapeutics Co
 
He Huang
No Relationships to Disclose
 
Xiaojun Huang
Research Funding - Innovative Cellular Therapeutics Co
 
Xiaoyan Ke
Research Funding - Innovative Cellular Therapeutics Co
 
Yu Hu
Research Funding - Innovative Cellular Therapeutics Co (Inst)
 
Junmin Li
Research Funding - Innovative Cellular Therapeutics Co (Inst)
 
Qing Zhang
Research Funding - Innovative Cellular Therapeutics Co (Inst)
 
Yongxian Hu
Research Funding - Innovative Cellular Therapeutics Co
 
Qian Jiang
Research Funding - Innovative Cellular Therapeutics Co
 
Jiong Hu
Research Funding - Innovative Cellular Therapeutics Co (Inst)
 
Hongmei Jing
Research Funding - Innovative Cellular Therapeutics Co (Inst)
 
Xiaohong Zhang
Research Funding - Innovative Cellular Therapeutics Co (Inst)
 
Zhao Wu
Employment - Innovative Cellular Therapeutics Co
Leadership - Innovative Cellular Therapeutics Co
Stock and Other Ownership Interests - Innovative Cellular Therapeutics Co
Honoraria - Innovative Cellular Therapeutics Co
Research Funding - Innovative Cellular Therapeutics Co
Patents, Royalties, Other Intellectual Property - Innovative Cellular Therapeutics Co